postpartum depression: FDA approves breakthrough pill for severe

FDA Approves New Pill for Postpartum Depression

Transdermal delivery of breakthrough therapeutics for the management of treatment-resistant and post-partum depression - ScienceDirect

Zuranolone, a breakthrough postpartum depression treatment, was just approved by the FDA. The fast-acting pill can improve symptoms in 3 days

Breakthrough treatment for postpartum depression gets FDA approval: All the details - Resources

Postpartum depression: FDA approves fast-acting pill Zurzuvae

Analysis: Zuranolone for postpartum depression: Hope, hype or both? – Brighter World

First Postpartum Depression Pill-US Approves

The FDA Has Approved the First-Ever Pill for Postpartum Depression – Mother Jones

Zurzuvae (Zuranolone) Fast Acting Postpartum Depression Pill